The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index; 46 of the 60 sources its claims cite were checked for support.
Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness
Open accessAbstract
Small colony variants are relatively common among some bacterial species and are associated with poor prognosis and recalcitrant infections. Similarly, Candida glabrata— a major intracellular fungal pathogen—produces small and slow-growing respiratory-deficient colonies, termed “petite.” Despite reports of clinical petite C. glabrata strains, our understanding of petite behavior in the host remains obscure. Moreover, controversies exist regarding in-host petite fitness and its clinical relevance. Herein, we employed whole-genome sequencing (WGS), dual-RNAseq, and extensive ex vivo and in vivo studies to fill this knowledge gap. WGS identified multiple petite-specific mutations in nuclear and mitochondrially encoded genes. Consistent with dual-RNAseq data, petite C. glabrata cells did not replicate inside host macrophages and were outcompeted by their non-petite parents in macrophages and in gut colonization and systemic infection mouse models. The intracellular petites showed hallmarks of drug tolerance and were relatively insensitive to the fungicidal activity of echinocandin drugs. Petite-infected macrophages exhibited a pro-inflammatory and type I IFN-skewed transcriptional program. Interrogation of international C. glabrata blood isolates ( n = 1000) showed that petite prevalence varies by country, albeit at an overall low prevalence (0%–3.5%). Collectively, our study sheds new light on the genetic basis, drug susceptibility, clinical prevalence, and host-pathogen responses of a clinically overlooked phenotype in a major fungal pathogen. Importance Candida glabrata is a major fungal pathogen, which is able to lose mitochondria and form small and slow-growing colonies, called “petite.” This attenuated growth rate has created controversies and questioned the clinical importance of petiteness. Herein, we have employed multiple omics technologies and in vivo mouse models to critically assess the clinical importance of petite phenotype. Our WGS identifies multiple genes potentially underpinning petite phenotype. Interestingly, petite C. glabrata cells engulfed by macrophages are dormant and, therefore, are not killed by the frontline antifungal drugs. Interestingly, macrophages infected with petite cells mount distinct transcriptomic responses. Consistent with our ex vivo observations, mitochondrial-proficient parental strains outcompete petites during systemic and gut colonization. Retrospective examination of C. glabrata isolates identified petite prevalence a rare entity, which can significantly vary from country to country. Collectively, our study overcomes the existing controversies and provides novel insights regarding the clinical relevance of petite C. glabrata isolates.
Overview
CoChat Summary
## TL;DR
This study shows that *Candida glabrata* petites are generally poor at intracellular growth and in vivo colonization, but they tolerate echinocandins better than non-petite cells and trigger a pro-inflammatory macrophage response. Across >1,000 blood isolates, petites were rare overall (0.9%) but varied by country (0%–3.3%).
## Key findings
- In THP-1 macrophages, petite isolates did not show intracellular growth, while non-petite isolates replicated at 24 and 48 hpi; petites were also more readily phagocytosed than non-petites.
- Dual RNA-seq showed that petite-infected macrophages induced pro-inflammatory pathways, including “Interferon alpha response,” “Interferon gamma response,” “TNFA signaling via NFKB,” and “Inflammatory response,” and were enriched for the human M1 transcriptional module.
- Petite isolates showed slower killing than non-petites under echinocandin exposure: they were significantly less susceptible to micafungin (0.125 µg/mL) and caspofungin (0.25 µg/mL), including inside macrophages; by contrast, they were killed similarly to non-petites by amphotericin B (2 µg/mL).
- In mouse models, petites were outcompeted by non-petite counterparts in gut colonization and systemic infection, but under caspofungin treatment their survival in vivo was higher than in untreated controls.
## Methods
- The study combined clinical and laboratory-derived *C. glabrata* petites with comparative genomics (WGS), macrophage infection assays in human THP-1 cells, dual RNA-seq, antifungal killing assays, and mouse gut colonization/systemic infection competition models.
- Clinical sampling included 37 isolates in the lab collection, plus a retrospective screen of >1,000 bloodstream isolates from Austria (n=600), Turkey (n=260), and Pakistan (n=220).
- Main analyses included variant calling from Illumina WGS, differential expression analysis with DESeq2, and gene set enrichment analysis (GSEA) / GO enrichment for host and fungal transcriptomes.
## Limitations
- The authors state that the underlying genetic drivers of the petite phenotype are “complex” and that the contribution of multiple genes is “yet to be fully determined.”
- They note that the lack of a closely related parental strain for DPL248 limited identification of recently acquired mutations.
- Evident from the text: the in vivo competition experiments were acute mouse infection/colonization models, which the authors themselves suggest may miss host niches or longer-term dynamics relevant to human persistence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
29 Valid · 4 Not valid · 5 Not checked · 114 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“previous studies found that petites and their non-petite progenitors have similar levels of membrane ergosterol (3), the target of amphotericin B”
§ Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness > RESULTS > Intracellular petites are non-responsive to echinocandins irrespective of drug concentration Because non-growth and slow growth in bacterial pathogens are associated with higher survival upon exposure to lethal concentrations of antibiotics (1, 5, 34), we hypothesized that C. glabrata petites could better survive lethal concentrations of cidal antifungal drugs. First, we tested whether our petites were more tolerant to general stresses, such as ER stress (tunicamycin), membrane assault (SDS), cell wall stress (Congo red), and oxidative stress (H2O2). The survival of strains BYP41 and D5 (petites) and BYP40 and CBS138 (non-petite parents) was assessed quantitatively using CFU enumeration at 3, 6, and 24 h post treatment (pt). Indeed, petites showed significantly higher survival under ER and membrane stresses, whereas they showed a similar tolerance to non-petites during cell wall and oxidative stresses (Fig. 4A). A higher tolerance to ER stress has already been described for other petite C. glabrata isolates (6). Next, we assessed the survival of petites and their non-petite parent strains at 3, 6, 24, and 48 hpt when treated with 8 × MIC of micafungin (0.125 µg/mL) and caspofungin (0.25 µg/mL). As hypothesized, petites exhibited a significantly slower killing rate than non-petite isolates, which mimicked microbial tolerance phenotypes characterized by slow and monophasic killing (34, 35) (Fig. 4B). Since C. glabrata can survive within macrophages and intracellular petites are dormant, we explored the impact of micafungin (0.125 µg/mL) and caspofungin (0.25 µg/mL) on intracellular petite and non-petite isolates. As expected, intracellular petites were not responsive to echinocandin treatment, whereas intracellular non-petites showed a significantly higher killing rate (Fig. 4C). The intracellular petites were not responsive to echinocandins irrespective of concentration and showed a much slower killing rate in RPMI compared to non-petite isolates (Fig. S4A). Of note, this was somewhat concentration- and time-dependent, as planktonic petites grown in RPMI showed killing rates similar to non-petites at lower concentrations of caspofungin (0.03 and 0.06 µg/mL) after 24 h (Fig. S4B). Consistent with results obtained with other petite strains, intracellular rdm9Δ cells were almost 100-fold more tolerant to micafungin (0.125 µg/mL) (Fig. S4C). To substantiate our findings, we established an intracellular competition assay in the presence of micafungin (0.125 µg/mL), and the proportions of GFP and RFP cells were determined by flow cytometry at 3 and 24 hpt. In agreement with our experiments on individual strains, petites had a competitive advantage and showed a significantly higher survival than non-petites (Fig. 4D and E; Fig. S5). Given that previous studies found that petites and their non-petite progenitors have similar levels of membrane ergosterol (3), the target of amphotericin B, and that the candidemia patient infected by BYP41 was successfully treated with amphotericin B (12), we reasoned that petites and non-petites should have similar killing rates by amphotericin B. In agreement with this expectation, petites and non-petites showed similar killing rates in both intracellular and planktonic conditions upon treatment with 2× MIC of amphotericin B (2 µg/mL) (Fig. 4F). Although echinocandins and amphotericin B are both cidal antifungal drugs, echinocandins’ cidality requires actively growing cells producing a cell wall, whereas amphotericin B indistinguishably kills growing and non-growing cells (36). Altogether, these observations suggest that petites have a fitness benefit relative to non-petites when exposed to echinocandin drugs but are killed as effectively as non-petite cells by polyene amphotericin B.
What the sources say
- Disputedcites [3] sourceExperimental — accuracy not yet measured
The Results (Sterol composition; page unavailable) report similar overall sterol amounts, but ergosterol made up about 50% of parent sterols and more than 90% of mutant sterols. The Discussion says increased free ergosterol would be incorporated into the plasma membrane, contrary to the claim of similar membrane ergosterol levels. (LLM, conf=0.92)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“petite C. glabrata shows resistance to fungistatic azole drugs due to overexpression of ABC transporters (CDR1, CDR2, and SNQ2) and their transcriptional regulator (PDR1)”
§ Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness > INTRODUCTION
What the sources say
- Not checked — no full text of the sourcecites [2] source
- Partly supportedcites [3] sourceExperimental — accuracy not yet measured
The Results and Discussion report increased CgCDR1 expression and a smaller increase in CgCDR2 expression in azole-resistant petite mutants. They describe resistance as associated with those changes, but do not establish overexpression of SNQ2 or PDR1 as part of the mechanism. (LLM, conf=0.90)
- Partly supportedcites [7] sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says the C. glabrata petite phenotype activates Pdr1 and upregulates its ABC-transporter targets CDR1 and CDR2, conferring azole resistance. The Discussion also reports expression of PDR1 and CDR1 in the authors’ petite strains. Our copy does not identify SNQ2 as an overexpressed transporter in these strains, so the full list in the claim is not supported. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [12] source
- Supportedcites [14] source
The Introduction (page unavailable) says that azole resistance in petite C. glabrata is caused by ABC-transporter upregulation mediated by CgPDR1. The Results section (page unavailable) identifies the petite isolate BPY41 as azole resistant and reports overexpression of CgCDR1, CgCDR2, CgSNQ2, and CgPDR1. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [15] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“petite cells are more effectively phagocytosed relative to non-petite strains (7)”
- Also stated in: § Intracellular petite cells are non-growing, dormant-like, and exert minimal damage to macrophages · plain
“petites had a significantly higher phagocytosis rate than non-petite isolates”
§ Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness > INTRODUCTION
What the sources say
- Supportedcites [7] source
The Results section reports that the petite C. glabrata Cgmip1Δ mutant was taken up by human macrophages at about 1.5 times the rate of the wild type. This directly supports the comparison, though the measured result concerns that mutant and wild-type comparator. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Intracellular petite cells are non-growing, dormant-like, and exert minimal damage to macrophages · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which may be attributed to their decreased level of β-1,3-d glucan and a compensatory increased level of mannan (7).”
§ Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness > DISCUSSION
What the sources say
- Partly supportedcites [7] sourceExperimental — accuracy not yet measured
The Results section (Fig. 2B; page not provided) reports slightly higher phagocytosis of the Cgmip1Δ mutant, increased mannan exposure, and slightly reduced β(1→3)-glucan exposure. The Discussion says increased mannan exposure can explain the higher phagocytosis rate. The paper measures surface exposure rather than total levels and does not say the mannan increase compensates for reduced glucan. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“their effect in the host has remained controversial, with some studies reporting substantially higher mortality and fungal burdens in petite strain-infected mice (14), whereas other studies have found otherwise (15, 17).”
§ Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness > INTRODUCTION
What the sources say
- Supportedcites [14] source
The Results section reports significantly increased virulence and higher kidney, spleen, and liver fungal burdens in mice infected with the petite isolate BPY41 than in mice infected with BPY40. The paper also notes a contrary finding for laboratory-derived petite mutants, but this source is cited for the higher-mortality-and-burden side of the comparison. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [15] source
- Supportedcites [17] source
The citation to this paper is attached to the studies that found otherwise, not to the preceding report of higher mortality and fungal burdens. In the Results section on murine fungal burden, the paper reports that kidneys and spleens from mice infected with its petite mutant were sterile; the Discussion describes this as avirulence and contrasts it with a report of enhanced virulence. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
101 more claims · 9 with their cited sources checked
Create a free account to see all 152 claims and every source verdict.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 30
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 8×
“Gene set enrichment analysis (GSEA) indicating significantly enriched “Hallmark” pathways of the Molecular Signatures Database, based on the RNA-seq data from THP-1 cells at 24 h post-fungal challenge.”
MethodInfluentialSTAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390 · cited 1×
“Additionally, we manually filtered out likely artifactual mutations through visual inspection using the integrative genomics viewer (58).”
MethodThe Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807 · cited 2×
“We tested enrichment of the “Hallmark” Molecular Signatures Database pathways (32) where weighted enrichment statistic was used with “Signal2Noise” as a metric for ranking genes.”
MultiQC: summarize analysis results for multiple tools and samples in a single report
Ewels, P., Magnusson, M., Lundin, S., & Käller, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw354 · Cited by 10,143
The Ensembl Variant Effect Predictor
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., Flicek, P., & Cunningham, F. (2016) · Genome Biology · doi:10.1186/s13059-016-0974-4 · Cited by 8,099
Li, H. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr509 · Cited by 6,486 · cited 1×
“All sequencing data were processed to call SNPs using Freebayes (51), HaplotypeCaller (52), and Bcftools (53) as implemented in PerSVade v 1.0 (54) and using the genome sequence of CBS138 A22-s07-m01-r86 as a reference (55).”
MethodInfluential
Cited by
Hoenigl, M., Arastehfar, A. A., Arendrup, M. C., Brüggemann, R. J. M., Carvalho, A., Chiller, T. M., Chen, W., Egger, M., Feys, S., Gangneux, J., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-23 · Cited by 181
Self-citationWeerasinghe, H., Stölting, H., Rose, A. J., & Traven, A. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00171-22 · Cited by 30
Arastehfar, A., Daneshnia, F., Floyd, D. J., Jeffries, N. E., Salehi, M., Perlin, D. S., Ilkit, M., Lass-Flöerl, C., & Mansour, M. K. (2024) · mBio · doi:10.1128/mbio.00072-24 · Cited by 19
Self-citationTrichosporon asahii : emerging challenges in pathogenesis and drug resistance
Zhang, H., & Zhang, J. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2457858 · Cited by 13
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 14
Metadata
- Authors
- Arastehfar, A., Daneshnia, F., Hovhannisyan, H., Fuentes, D., Cabrera, N., Quinteros, C., Ilkit, M., Ünal, N., Hilmioğlu-Polat, S., Jabeen, K., Zaka, S., Desai, J. V., Lass-Flörl, C., Shor, E., Gabaldon, T., & Perlin, D. S.
- Affiliations
- Harvard University (US)
- Barcelona Supercomputing Center (ES)
- Division of Mycology, Faculty of Medicine, University of Çukurova , Adana, Turkey
- Cukurova University (TR)
- Division of Mycology, Faculty of Medicine, University of Ege , Izmir, Turkey
- Aga Khan University (PK)
- Hackensack Meridian Health (US)
- Medical University of Innsbruck , Innsbruck, Austria
- Life Sciences Programme, Supercomputing Center (BSC-CNS) , Barcelona, Spain
- Corresponding author
- Perlin, David S.
- ORCID
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2023-10-31
- Volume
- 14
- Issue
- 5
- Pages
- e0118023-e0118023
- ISSN
- 2150-7511 (ISSN-L)
- PMC
- PMC10653939
- OpenAlex
- W4387157203
- Semantic Scholar
- fc6f04f019a597faef86b5f3d3fdb6cba92fab52
- Cited by
- 27
- References
- 65
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 6
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mBio (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- eCommons - AKU (Aga Khan University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HHS | National Institutes of Health (R01AI109025)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida glabrata, small colony variants, antifungal resistance, macrophage infection, host inflammatory response, type I interferon, mitochondrial mutations, in vivo fitness, intestinal colonization, systemic infection, clinical isolates, fungal pathogens, host-pathogen interaction, respiratory deficiency, intracellular survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness. https://app.cochat.ai/papers/10.1128/mbio.01180-23
- The paper
- Arastehfar, A., Daneshnia, F., Hovhannisyan, H., Fuentes, D., Cabrera, N., Quinteros, C., Ilkit, M., Ünal, N., Hilmioğlu-Polat, S., Jabeen, K., Zaka, S., Desai, J. V., Lass-Flörl, C., Shor, E., Gabaldon, T., & Perlin, D. S. (2023). Overlooked Candida glabrata petites are echinocandin tolerant, induce host inflammatory responses, and display poor in vivo fitness. mBio. https://doi.org/10.1128/mbio.01180-23
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.